NIATx News
-
JCOIN Project Expands Access to Life-Saving Medications for Opioid Use Disorder in Jails
From the Justice Community Overdose Innovation Network Newsletter, March 2025 In a recent study published in Implementation Science, researchers from JCOIN’s Coordination and Translation Center (CTC) examined strategies to provide more effective…
-
Updates to Requirements for Buprenorphine Prescribing
In January 2023, SAMHSA announced that clinicians no longer need a federal waiver to prescribe buprenorphine for treating opioid use disorder. However, clinicians are still required to register with the Drug Enforcement…
-
New Research Publications Highlight NIATx Versatility
Recent projects have used the NIATx approach to explore coaching, how patients use mobile health apps, and how to recruit prescribers for medications for opioid use disorder (MOUD). Coaching as an implementation…
-
Using the Cascade of Care to Increase Medications for Opioid Use Disorder in CJ Settings
The opioid epidemic has had a disproportionate impact on the nation’s criminal justice (CJ) population. Justice-involved individuals with opioid use disorders (OUD) desperately need evidence-based translational practices to implement medication for opioid…
-
NIATx project explores reducing no-shows in dental settings
The NIATx Dental Pilot study tested using the NIATx model for organizational change to reduce appointment no-shows in dental care settings. The NIATx model was applied through a multisite learning collaborative that…